This is consistent with the result here that A549 and MDA-MB-231 cancer cells harboring K-RAS mutations are more susceptible to the 12-deoxyphorbol esters than H1299 and MCF-7 cancer cells expressing wild-type K-RAS. Here, KRAS is linked to cancer.